Close

ImpediMed

What

Bioimpedance medical devices

CEO

Richard Carreon

Investment Director

Michael Panaccio

Investment Date

June 2006

ImpediMed is a medical device company that designs, develops and markets proprietary bioimpedance analysis systems for use in non-invasive screening and monitoring of human disorders and diseases. ImpediMed markets products in three core areas, body composition for medical applications, hydration status monitoring and the detection and monitoring of lymphoedema and oedema.

Impedimed was listed on the Australian Stock Exchange in October 2007 (ASX:IPD).